Literature DB >> 20123066

HMG modifications and nuclear function.

Qingchun Zhang1, Yinsheng Wang.   

Abstract

High mobility group (HMG) proteins assume important roles in regulating chromatin dynamics, transcriptional activities of genes and other cellular processes. Post-translational modifications of HMG proteins can alter their interactions with DNA and proteins, and consequently, affect their biological activities. Although the mechanisms through which these modifications are involved in regulating biological processes in different cellular contexts are not fully understood, new insights into these modification "codes" have emerged from the increasing appreciation of the functions of these proteins. In this review, we focus on the chemical modifications of mammalian HMG proteins and highlight their roles in nuclear functions. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20123066      PMCID: PMC2818492          DOI: 10.1016/j.bbagrm.2009.11.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  130 in total

1.  HMGA1 protein is a novel target of the ATM kinase.

Authors:  Francesca Pentimalli; Dario Palmieri; Roberto Pacelli; Corrado Garbi; Rossano Cesari; Eric Martin; Giovanna Maria Pierantoni; Paolo Chieffi; Carlo Maria Croce; Vincenzo Costanzo; Monica Fedele; Alfredo Fusco
Journal:  Eur J Cancer       Date:  2008-09-08       Impact factor: 9.162

2.  Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages.

Authors:  Xianghong Zhang; David Wheeler; Ying Tang; Lanping Guo; Richard A Shapiro; Thomas J Ribar; Anthony R Means; Timothy R Billiar; Derek C Angus; Matthew R Rosengart
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome.

Authors:  N Munshi; M Merika; J Yie; K Senger; G Chen; D Thanos
Journal:  Mol Cell       Date:  1998-10       Impact factor: 17.970

Review 4.  The high mobility group protein, HMGI-C.

Authors:  G Goodwin
Journal:  Int J Biochem Cell Biol       Date:  1998-07       Impact factor: 5.085

5.  HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism.

Authors:  Young Joo Oh; Ju Ho Youn; Yeounjung Ji; Sang Eun Lee; Kook Jin Lim; Ji Eun Choi; Jeon-Soo Shin
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

Review 6.  HMGB1: a two-headed signal regulating tumor progression and immunity.

Authors:  Lara Campana; Lidia Bosurgi; Patrizia Rovere-Querini
Journal:  Curr Opin Immunol       Date:  2008-07-01       Impact factor: 7.486

Review 7.  Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies.

Authors:  Lionel Apetoh; Antoine Tesniere; François Ghiringhelli; Guido Kroemer; Laurence Zitvogel
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

8.  High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage.

Authors:  Sabine S Lange; David L Mitchell; Karen M Vasquez
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

9.  Activation of ATM depends on chromatin interactions occurring before induction of DNA damage.

Authors:  Yong-Chul Kim; Gabi Gerlitz; Takashi Furusawa; Frédéric Catez; Andre Nussenzweig; Kyu-Seon Oh; Kenneth H Kraemer; Yosef Shiloh; Michael Bustin
Journal:  Nat Cell Biol       Date:  2008-12-14       Impact factor: 28.824

Review 10.  Therapeutic potential of HMGB1-targeting agents in sepsis.

Authors:  Haichao Wang; Shu Zhu; Rongrong Zhou; Wei Li; Andrew E Sama
Journal:  Expert Rev Mol Med       Date:  2008-11-04       Impact factor: 5.600

View more
  29 in total

Review 1.  The Necessity of Chromatin: A View in Perspective.

Authors:  Vincenzo Pirrotta
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-01-04       Impact factor: 10.005

2.  Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.

Authors:  Ruiguang Zhang; Yan Li; Zhongliang Wang; Lingjuan Chen; Xiaorong Dong; Xiu Nie
Journal:  Tumour Biol       Date:  2015-06-04

3.  SIRT6-PARP1 is involved in HMGB1 polyADP-ribosylation and acetylation and promotes chemotherapy-induced autophagy in leukemia.

Authors:  Qian Kong; Yunyao Li; Qixiang Liang; Jianwei Xie; Xinyu Li; Jianpei Fang
Journal:  Cancer Biol Ther       Date:  2020-01-13       Impact factor: 4.742

4.  Spatiotemporal gene expression patterns reveal molecular relatedness between retinal laminae.

Authors:  Danye Jiang; Courtney A Burger; Anna K Casasent; Nicholas E Albrecht; Fenge Li; Melanie A Samuel
Journal:  J Comp Neurol       Date:  2019-10-31       Impact factor: 3.215

Review 5.  The Genomes of Three Uneven Siblings: Footprints of the Lifestyles of Three Trichoderma Species.

Authors:  Monika Schmoll; Christoph Dattenböck; Nohemí Carreras-Villaseñor; Artemio Mendoza-Mendoza; Doris Tisch; Mario Ivan Alemán; Scott E Baker; Christopher Brown; Mayte Guadalupe Cervantes-Badillo; José Cetz-Chel; Gema Rosa Cristobal-Mondragon; Luis Delaye; Edgardo Ulises Esquivel-Naranjo; Alexa Frischmann; Jose de Jesus Gallardo-Negrete; Monica García-Esquivel; Elida Yazmin Gomez-Rodriguez; David R Greenwood; Miguel Hernández-Oñate; Joanna S Kruszewska; Robert Lawry; Hector M Mora-Montes; Tania Muñoz-Centeno; Maria Fernanda Nieto-Jacobo; Guillermo Nogueira Lopez; Vianey Olmedo-Monfil; Macario Osorio-Concepcion; Sebastian Piłsyk; Kyle R Pomraning; Aroa Rodriguez-Iglesias; Maria Teresa Rosales-Saavedra; J Alejandro Sánchez-Arreguín; Verena Seidl-Seiboth; Alison Stewart; Edith Elena Uresti-Rivera; Chih-Li Wang; Ting-Fang Wang; Susanne Zeilinger; Sergio Casas-Flores; Alfredo Herrera-Estrella
Journal:  Microbiol Mol Biol Rev       Date:  2016-02-10       Impact factor: 11.056

6.  Increased expression of high-mobility group nucleosomal-binding domain 2 protein in various tumor cell lines.

Authors:  Qian Li; Jiao Chen; Xiaoying Li; Bomiao Cui; Yaping Fan; Ning Geng; Qianming Chen; Ping Zhang; Yun Feng
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

Review 7.  Interplay between HMGA and TP53 in cell cycle control along tumor progression.

Authors:  Nathalia Meireles Da Costa; Antonio Palumbo; Marco De Martino; Alfredo Fusco; Luis Felipe Ribeiro Pinto; Luiz Eurico Nasciutti
Journal:  Cell Mol Life Sci       Date:  2020-09-12       Impact factor: 9.261

Review 8.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

9.  Quantitation and Identification of Thousands of Human Proteoforms below 30 kDa.

Authors:  Kenneth R Durbin; Luca Fornelli; Ryan T Fellers; Peter F Doubleday; Masashi Narita; Neil L Kelleher
Journal:  J Proteome Res       Date:  2016-02-11       Impact factor: 4.466

10.  Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latency.

Authors:  Cory H White; Harvey E Johnston; Bastiaan Moesker; Antigoni Manousopoulou; David M Margolis; Douglas D Richman; Celsa A Spina; Spiros D Garbis; Christopher H Woelk; Nadejda Beliakova-Bethell
Journal:  Antiviral Res       Date:  2015-09-04       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.